Core outcomes in gestational diabetes for treatment trials: The Gestational Metabolic Group treatment set. (3rd February 2021)

• Record Type: Journal Article
• Authors: Bashir, Mohammed; Syed, Asma; Furuya‐Kanamori, Luis; Musa, Omran A. H.; Mohamed, Aisha M.; Skarulis, Monica; Thalib, Lukman; Konje, Justin C.; Abou‐Samra, Abdul‐Badi; Doi, Suhail A. R.
• Is Part Of: Obesity science and practice. Volume 7:Number 3(2021)
• Page Start: 251
• Page End: 259
• Publication Date: 2021-02-03
• Subjects: core measurement set -- core outcome set -- gestational diabetes -- treatment trials; Obesity -- Periodicals; 616.398005
• DOI: 10.1002/osp4.480
• Languages: English
• ISSNs: 2055-2238

Abstract

Abstract: Aims: With the rising number of outcomes being reported following gestational diabetes (GDM), the outcomes in existing studies vary widely making it challenging to compare and contrast the effectiveness of different interventions for GDM. The purpose of this study was to develop a core outcome and measurement set (COS) for GDM treatment trials. Materials & Methods: A Delphi study with structured consultation with stakeholders and discussion within a specialist Gestational Metabolic Group (GEM) were combined with a comprehensive systematic search across different databases (PubMed, Cochrane Library, and Embase). Several Delphi rounds over 2 years were conducted culminating in this report. Results: The process resulted in a targeted set of outcomes constituting a "GEM treatment set" aligned with expert opinion. The final COS also included a measurement set for the 11 important clinical outcomes from three major domains: maternal metabolic, fetal, and pregnancy related. Conclusions: Based on the results of this study, it is recommended that future clinical trials on GDM report outcomes uniformly keeping to the recommended COS outcomes.